Literature DB >> 19587753

Vision: New light on allergy receptor.

Maria Grant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587753     DOI: 10.1038/460182a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  Risk factors for age-related macular degeneration: Pooled findings from three continents.

Authors:  W Smith; J Assink; R Klein; P Mitchell; C C Klaver; B E Klein; A Hofman; S Jensen; J J Wang; P T de Jong
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

4.  Neutrophils promote experimental choroidal neovascularization.

Authors:  Jiehao Zhou; Lucia Pham; Ning Zhang; Shikun He; Maria-Andreea Gamulescu; Christine Spee; Stephen J Ryan; David R Hinton
Journal:  Mol Vis       Date:  2005-06-16       Impact factor: 2.367

5.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation.

Authors:  Weilie Ma; Paul J Bryce; Alison A Humbles; Dhafer Laouini; Ali Yalcindag; Harri Alenius; Daniel S Friend; Hans C Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness.

Authors:  Alison A Humbles; Bao Lu; Daniel S Friend; Shoji Okinaga; Jose Lora; Amal Al-Garawi; Thomas R Martin; Norma P Gerard; Craig Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

7.  Macrophage depletion inhibits experimental choroidal neovascularization.

Authors:  Eiji Sakurai; Akshay Anand; Balamurali K Ambati; Nico van Rooijen; Jayakrishna Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

8.  Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Amanda A Honeycutt; Sarah B Lesesne; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2009-04

9.  CCR3 is a target for age-related macular degeneration diagnosis and therapy.

Authors:  Atsunobu Takeda; Judit Z Baffi; Mark E Kleinman; Won Gil Cho; Miho Nozaki; Kiyoshi Yamada; Hiroki Kaneko; Romulo J C Albuquerque; Sami Dridi; Kuniharu Saito; Brian J Raisler; Steven J Budd; Pete Geisen; Ariel Munitz; Balamurali K Ambati; Martha G Green; Tatsuro Ishibashi; John D Wright; Alison A Humbles; Craig J Gerard; Yuichiro Ogura; Yuzhen Pan; Justine R Smith; Salvatore Grisanti; M Elizabeth Hartnett; Marc E Rothenberg; Jayakrishna Ambati
Journal:  Nature       Date:  2009-06-14       Impact factor: 49.962

10.  Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.

Authors:  Magali Saint-Geniez; Arindel S R Maharaj; Tony E Walshe; Budd A Tucker; Eiichi Sekiyama; Tomoki Kurihara; Diane C Darland; Michael J Young; Patricia A D'Amore
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.